Letrozole API
CAS 112809-51-5Hormone Modulators & Antagonists
Overview
Letrozole is supplied by Swapnroop Hormones & Steroids as an active pharmaceutical ingredient for licensed pharmaceutical manufacturers. Aromatase inhibitor for breast cancer and fertility protocols. It is part of our Hormone Modulators & Antagonists range.
Supply details
- CAS number
- 112809-51-5
- Product family
- Hormone Modulators & Antagonists
- Typical use
- Aromatase inhibitor for breast cancer and fertility protocols.
- Pharmacopoeial grade
- USP / BP / EP / IP. Please state the monograph you require.
- Appearance
- Typically a white to off-white powder; see the COA for the batch.
- Documents
- COA and MSDS with each batch; specification and technical data on request.
- Packing
- Double polythene-lined drums or containers; custom sizes on request.
- Storage
- Tightly closed container, protected from light and moisture, at controlled room temperature unless the COA states otherwise.
- Supplied to
- Licensed pharmaceutical manufacturers and laboratories only.
Specifications are indicative. Batch-specific values are stated on the certificate of analysis. Please confirm grade, availability and minimum order quantity when you enquire.
More from Hormone Modulators & Antagonists
ExemestaneSteroidal aromatase inactivator for breast cancer therapy.107868-30-4Hormone Modulators & Antagonists
Tamoxifen CitrateSelective estrogen receptor modulator for breast cancer therapy.54965-24-1Hormone Modulators & Antagonists
Toremifene CitrateSelective estrogen receptor modulator for breast cancer therapy.89778-27-8Hormone Modulators & Antagonists
FulvestrantEstrogen receptor antagonist for injectable oncology products.129453-61-8Hormone Modulators & Antagonists
Raloxifene HydrochlorideSelective estrogen receptor modulator for osteoporosis.82640-04-8Hormone Modulators & Antagonists
Get in touch
Tell us the product, grade and quantity.
We reply with availability, specification and documents within one working day.